Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3077

Actual shortage: 235 (8%)
Anticipated shortage: 16 (1%)
Avoided shortage: 9 (0%)
Resolved: 2817 (92%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-CITALOPRAM 20MG TABLET Actual shortage 2024-04-26 2024-04-26 226312
APO-LEFLUNOMIDE 20MG TABLET Resolved 2024-04-26 2024-05-31 226315
APO-CITALOPRAM 20MG TABLET Actual shortage 2024-04-26 2024-04-26 226324
APO-PANTOPRAZOLE 20MG TABLET (DELAYED-RELEASE) Resolved 2024-05-03 2024-05-31 227034
APO-ESOMEPRAZOLE 20MG TABLET (DELAYED-RELEASE) Resolved 2024-05-03 2024-05-31 227073
APO-OMEPRAZOLE 20MG CAPSULE (DELAYED RELEASE) Actual shortage 2024-05-31 2024-06-06 229430
APO-PREGABALIN 225MG CAPSULE Resolved 2017-08-08 2017-09-22 18553
APO-PREGABALIN 225MG CAPSULE Resolved 2021-04-16 2021-04-26 137595
APO-PREGABALIN 225MG CAPSULE Anticipated shortage 2024-01-19 2024-01-19 216729
APO-VERAP SR 240MG TABLET (EXTENDED-RELEASE) Actual shortage 2017-03-10 2019-12-04 255
APO-DILTIAZ CD 240MG CAPSULE (CONTROLLED-DELIVERY) Resolved 2017-03-12 2018-12-18 716
APO-DILTIAZ CD 240MG CAPSULE (CONTROLLED-DELIVERY) Resolved 2017-06-28 2018-12-18 14168
APO-DOCUSATE CALCIUM 240MG CAPSULE Actual shortage 2017-08-14 2017-10-05 19120
APO-DILTIAZ CD 240MG CAPSULE (CONTROLLED-DELIVERY) Resolved 2019-02-13 2019-07-12 75614
APO-DILTIAZ CD 240MG CAPSULE (CONTROLLED-DELIVERY) Resolved 2019-02-24 2019-07-12 76714
APO-DILTIAZ CD 240MG CAPSULE (CONTROLLED-DELIVERY) Resolved 2019-08-07 2019-10-15 91073
APO-DILTIAZ CD 240MG CAPSULE (CONTROLLED-DELIVERY) Resolved 2019-09-04 2019-10-15 92965
APO-HYDROMORPHONE CR 24MG CAPSULE (EXTENDED RELEASE) Resolved 2019-03-05 2020-04-04 77855
APO-HYDROMORPHONE CR 24MG CAPSULE (EXTENDED RELEASE) Resolved 2019-03-20 2020-04-04 79039
APO-AMOXI CLAV 250MG 125MG TABLET Resolved 2020-01-15 2020-02-19 103357

Showing 1421 to 1440 of 3077

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-TERAZOSIN 2MG TABLET Discontinued 2017-03-31 2018-02-05 4974
APO-SALVENT TABLETS - 2MG 2MG TABLET Discontinued 2018-02-23 2018-12-28 40854
APO-TOLTERODINE 2MG TABLET Discontinued 2018-09-08 2018-11-09 60825
APO-TOLTERODINE 2MG TABLET Discontinued 2018-09-08 2019-06-12 60828
APO-RISPERIDONE 3.0MG TABLET Discontinued 2018-09-08 2019-06-12 60750
APO-CARVEDILOL 3.125MG TABLET To be discontinued 2024-01-26 2024-01-26 217496
APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE 300MG 150MG 300MG TABLET Discontinued 2022-12-12 2022-12-12 177953
APO-DILTIAZ TZ 300MG CAPSULE (EXTENDED RELEASE) Discontinued 2017-03-13 2017-03-13 1075
APO-NIZATIDINE 300MG CAPSULE Discontinued 2017-03-13 2017-03-13 1135
APO-GEMFIBROZIL CAP 300MG USP 300MG CAPSULE Discontinued 2017-03-31 2018-12-07 4920
APO-CLINDAMYCIN 300MG CAPSULE Discontinued 2018-09-07 2019-07-13 60399
APO-IBUPROFEN 300MG TABLET Discontinued 2018-09-07 2018-09-15 60527
APO-IRBESARTAN 300MG TABLET Discontinued 2018-09-07 2018-09-15 60539
APO-LAMIVUDINE 300MG TABLET Discontinued 2018-09-07 2019-07-13 60560
APO-LITHIUM CARBONATE 300MG CAPSULE Discontinued 2018-09-07 2018-09-15 60588
APO-QUETIAPINE 300MG TABLET Discontinued 2018-09-08 2018-12-28 60708
APO-QUININE 300MG CAPSULE Discontinued 2018-09-08 2021-05-10 60714
APO-RANITIDINE TABLET 300MG 300MG TABLET Discontinued 2018-09-08 2018-09-15 60729
APO-RANITIDINE TABLET 300MG 300MG TABLET To be discontinued 2018-09-08 2018-09-08 60732
APO-IBUPROFEN 300MG TABLET Discontinued 2019-01-02 2019-01-02 70793

Showing 221 to 240 of 356